TELA Bio Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
TELA Nasdaq 3841 http://www.telabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for TELA Bio Inc

TELA Bio to Participate in the Jefferies Global Healthcare Conference - May 25th, 2023 11:00 am
What You Can Learn From TELA Bio, Inc.'s (NASDAQ:TELA) P/S - May 21st, 2023 2:30 pm
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab - May 19th, 2023 11:00 am
Q1 2023 TELA Bio Inc Earnings Call - May 12th, 2023 11:44 am
TELA Bio, Inc. (TELA) Reports Q1 Loss, Misses Revenue Estimates - May 11th, 2023 9:25 pm
TELA Bio Reports First Quarter 2023 Financial Results - May 11th, 2023 8:02 pm
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference - May 9th, 2023 11:00 am
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 8th, 2023 8:30 pm
TELA Bio to Participate in the JMP Securities Life Sciences Conference - May 2nd, 2023 11:00 am
TELA Bio, Inc. (NASDAQ:TELA) stock most popular amongst private equity firms who own 36%, while individual investors hold 26% - Apr 30th, 2023 12:26 pm
Dlocal and Augmedix Stock See Action From Activist Investors - Apr 28th, 2023 10:47 pm
TELA Bio to Announce First Quarter 2023 Financial Results - Apr 27th, 2023 11:00 am
TELA Bio Announces Pricing of Public Offering of Common Stock - Apr 19th, 2023 3:00 am
TELA Bio Announces Proposed Public Offering of Common Stock - Apr 18th, 2023 8:01 pm
TELA Bio's (NASDAQ:TELA) investors will be pleased with their notable 34% return over the last three years - Apr 3rd, 2023 10:14 am
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023 - Mar 29th, 2023 11:00 am
TELA Bio, Inc. (NASDAQ:TELA) Q4 2022 Earnings Call Transcript - Mar 24th, 2023 11:15 am
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery - Mar 23rd, 2023 11:00 am
Q4 2022 TELA Bio Inc Earnings Call - Mar 22nd, 2023 10:01 am
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Mar 21st, 2023 9:15 pm